News and Media

News and Media

  • Sitavig® Licensing Strategy: Execution of licensing agreement with Innocutis for North America and Positive opinion from French and German Health Authorities for Marketing Authorization

    March 19, 2014

  • Strengthening and extension of the industrial protection of Livatag® until 2031 – First delivery of a new European patent

    February 18, 2014

  • BioAlliance Pharma’s partner, Sosei, announces a partnership with FUJIFILM Pharma for commercialization rights for Loramyc® in Japan

    February 4, 2014

  • FDA grants Validive® (clonidine Lauriad®) with a Fast Track Designation for the prevention and treatment of oral mucositis induced by anticancer treatments

    January 23, 2014

  • Quarterly information as of September 30, 2013

    November 14, 2013

  • Key milestones and consolidated accounts First semester 2013

    September 19, 2013

  • Bioalliance Pharma updates on major achievements of 2012 and publishes its 2012 consolidated financial statements and income for Q1 2013

    April 15, 2013

  • Quarterly information as of September 30, 2012 • A dynamic progression of BioAlliance Pharma portfolio Orphan

    November 14, 2012

  • Key milestones and consolidated accounts for the first semester of 2012

    September 13, 2012

  • Full-year financial results for 2011 • Q1 2012 Consolidated turnover

    April 17, 2012

  • 2011 achievements and 2012 prospects

    January 26, 2012

  • BioAlliance Pharma reports its consolidated turnover for Q3 And announces progress for Loramyc® commercialization in Italy

    November 14, 2011

  • Consolidated accounts for the first semester of 2011 and recent significant key events

    September 21, 2011

  • Q2 2011: BioAlliance Pharma accelerates the progress of its “Orphan oncology products” portfolio and pursues its international partnerships on its “Specialty products”

    July 28, 2011

  • Q1 2011: achievement of key milestones in BioAlliance Pharma’s clinical development program

    May 13, 2011

Press Release Signup

Subscribe to receive our Press Releases when they come out.